Natco Pharma is dominant in the domestic oncology and gastro hepatology segments with a niche portfolio of 28 products including the generic version of Gilead's Sovaldi. Company's manufacturing facilities are vertically integrated with strong inhouse API development and complex products in finished dosage formulations. In bid to diversify its products segment it has...